/R E P E A T -- Notice to the media - Government of Canada officials to hold a technical briefing on COVID-19 vaccines in Canada/
OTTAWA, ON, April 1, 2021 /CNW/ - Government of Canada officials will hold a technical briefing to provide an overview on the roll-out of COVID-19 vaccines.
Officials will be available to answer questions from the media following their remarks.
Date April 1, 2021
Time 12:00 PM (EDT)
Location
The media technical briefing will be held virtually. Media will be able to ask questions via teleconference.
Toll-free (Canada/US) dial-in number: 1-866-206-0153 Local dial-in number: 613-954-9003
Passcode: 1622050#
To obtain the briefing material under embargo, please RSVP by email at [email protected].
NOTE: To help ensure optimal simultaneous interpretation sound quality, journalists are encouraged to use a microphone (headphones/headset) or, when possible, a landline, and to avoid using speaker mode if queuing up for questions.
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference.
On April 26, 2024, the hearing will commence 11:15 a.m.
Members of the public may observe the hearing by videoconference, by...
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...
